Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Research Square|June 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancerJuan C Osorio, David A Knorr, Polina Weitzenfeld, et al.
Journal of Skin Cancer|August 12, 2022
Interest and Utility of <i>MC1R</i> Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin CancerJennifer L Hay, Erica H Lee, Stephanie N Christian, et al.
Cancer Research|August 4, 2004
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancersTari A King, Mary L Gemignani, Weiwei Li, et al.
Annals of Surgical Oncology|June 29, 2007
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesisTari A King, Weiwei Li, Edi Brogi, et al.
Breast Cancer Research and Treatment|November 3, 2016
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer familyCiyu Yang, Angela G Arnold, Magan Trottier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
JCO Precision Oncology|July 12, 2021
Tolerability of Breast Radiotherapy Among Carriers of <i>ATM</i> Germline VariantsLeslie A Modlin, Jessica Flynn, Zhigang Zhang, et al.
Journal of the National Cancer Institute|September 22, 2005
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer familiesNoah D Kauff, Nandita Mitra, Mark E Robson, et al.
European Journal of Radiology|November 21, 2017
Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot studyMaxine S Jochelson, Katja Pinker, D David Dershaw, et al.
Breast Cancer Research and Treatment|May 7, 2013
Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysisCarmen A Perez, Zachary S Zumsteg, Gaorav Gupta, et al.
Pageof 18